You are here

Article Text

Article menu
Download PDFPDF
Articles
▼Paclitaxel for ovarian cancer

  • Relevant BNF section: 8.1.5

Abstract

Paclitaxel (Taxol - Bristol-Myers Squibb) is the first of a new group of cytotoxic drugs, the taxanes. It is licensed for the treatment of patients with metastatic ovarian carcinoma "where standard, platinum-containing, therapy has failed". What is its place in treatment?

https://doi.org/10.1136/dtb.1994.32641

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.